|
시장보고서
상품코드
2075107
맞춤형 유전체학 시장 : 검사 유형별, 기술별, 용도별, 최종사용자별, 지역별Personalized Genomics Market, By Test Type, By Technology, By Application, By End User, By Geography |
||||||
맞춤형 유전체학 시장 규모는 2026년에 147억 3,000만 달러로 추정되고 있으며, 2033년까지 452억 9,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 17.4%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 147억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 17.40% | 2033년 시장 규모 예측 : | 452억 9,000만 달러 |
개인 맞춤형 유전체학은 유전학, 유전체학 및 맞춤형 의료를 융합하여 개인의 유전적 구성에 관한 귀중한 인사이트를 제공하는 급속히 성장하고 있는 분야입니다.
시장 역학 :
전 세계 맞춤형 유전체학 시장은 몇 가지 요인에 의해 주도되고 있습니다. 첫째, 만성질환 유병률의 증가와 맞춤형 치료 옵션에 대한 수요 증가가 유전자 검사 서비스에 대한 수요를 창출하고 있습니다. 개인 맞춤형 유전체학은 특정 질환 발병 위험이 높은 개인을 파악하는 데 도움이 되며, 조기 개입과 표적 치료를 가능하게 합니다. 예를 들어 2020년 9월 'Preventing Chronic Disease'지에 실린 기사에 따르면 2018년에는 시설에 입소하지 않은 일반 성인의 51.8%가 선정된 10가지 만성질환 중 적어도 하나에 걸린 것으로 진단받았습니다. 더 구체적으로 말하면, 성인의 24.6%는 만성질환을 하나 앓고 있으며, 27.2%는 두 가지 이상의 만성질환을 앓고 있습니다.
또한 차세대 염기서열 분석 및 생물정보학 같은 기술의 발전으로 인해 유전자 검사는 더욱 이용하기 쉬워지고 가격도 저렴해졌습니다. 이에 따라 맞춤형 유전체학 서비스를 제공하는 기업의 고객 기반이 확대되고 있습니다.
그러나 시장에는 일정한 제약도 존재합니다. 유전 정보는 기밀성이 매우 높으며, 적절히 보호되지 않으면 악용될 가능성이 있으므로 개인정보 보호 및 데이터 보안에 대한 우려가 제기되고 있습니다. 또한 규제상 과제와 유전 데이터의 활용 및 해석에 관한 명확한 지침의 필요성도 시장 성장에 있으며, 과제로 대두되고 있습니다.
이러한 과제가 있음에도 불구하고 맞춤형 유전체학 시장에는 큰 기회가 존재합니다. 유전자 분석에 인공지능 및 기계학습 알고리즘을 통합함으로써, 맞춤형 유전체학 서비스의 정확성과 효율성을 높일 수 있습니다. 또한 소비자 대상 직접 유전자 검사의 확대와 의료 현장에서 유전자 검사 도입이 증가함에 따라 이 시장의 기업에게는 유망한 성장 기회가 열리고 있습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 맞춤형 유전체학 시장의 주요 기업 개요을 작성하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 세계의 ‘맞춤형 유전체학’ 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 맞춤형 유전체학 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 맞춤형 유전체학 시장 : 검사 유형별, 2021-2033년
제5장 세계의 맞춤형 유전체학 시장 : 기술별, 2021-2033년
제6장 세계의 맞춤형 유전체학 시장 : 용도별, 2021-2033년
제7장 세계의 맞춤형 유전체학 시장 : 최종사용자별, 2021-2033년
제8장 세계의 맞춤형 유전체학 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.07.07Personalized Genomics Market is estimated to be valued at USD 14.73 Bn in 2026 and is expected to reach USD 45.29 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 14.73 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 17.40% | 2033 Value Projection: | USD 45.29 Bn |
Personalized genomics is a rapidly growing field that combines genetics, genomics, and personalized medicine to provide individuals with valuable insights into their genetic makeup.
Market Dynamics:
The global personalized genomics market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the need for personalized treatment options have created a demand for genetic testing services. Personalized genomics can help identify individuals who are at a higher risk of developing certain diseases, allowing for early intervention and targeted treatment. For instance, in September 2020, according to an article published in Preventing Chronic Disease, in 2018, 51.8% of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. More specifically, the 24.6% of adults have 1 chronic condition, and 27.2% have more than two chronic conditions.
Additionally, advancements in technology, such as next-generation sequencing and bioinformatics, have made genetic testing more accessible and affordable. This has led to a growing consumer base for companies offering personalized genomics services.
However, there are also certain restraints in the market. Concerns about privacy and data security have been raised, as genetic information is highly sensitive and can be misused if not properly protected. Regulatory challenges and the need for clear guidelines regarding the use and interpretation of genetic data also pose challenges to market growth.
Despite these challenges, the personalized genomics market presents significant opportunities. The integration of artificial intelligence and machine learning algorithms in genetic analysis can enhance the accuracy and efficiency of personalized genomics services. Additionally, the expansion of direct-to-consumer genetic testing and the increasing adoption of genetic testing in healthcare settings offer promising growth prospects for companies in this market.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global personalized genomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Personalized Genomics; 23andMe, Mapmygenome, Invitea, Genetic Technology Limited, Lonza, Interleukin Genetics, Inc, GNA Genotek, Helix, MyHeritage, Pathway Genomics, Veritas Genetics, Xcode, Color Genomics, Myriad Genetics, Quest Diagnostics, Bio-Rad Laboratories, Inc., Illumina, Thermo Fisher Scientific, Qiagen, Genomic Health, Nebula Genomics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global personalized genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized genomics market
Personalized Genomics Market Detailed Segmentation:
- By Test Type (Revenue, USD Bn, 2021 - 2033)
- Oncology Testing
- Infectious Disease Testing
- Neurological Testing
- Cardiovascular Testing
- Others
- By Technology (Revenue, USD Bn, 2021 - 2033)
- PCR-based Tests
- Microarray-based Tests
- Sequencing-based Tests
- Others
- By Application (Revenue, USD Bn, 2021 - 2033)
- Diagnostics
- Precision Medicine
- Wellness
- Reproductive Health
- Sports Nutrition & Health
- Lifestyle
- Others
- By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals & Clinics
- Research Centers
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- 23andMe
- Mapmygenome
- Invitea
- Genetic Technology Limited
- Lonza
- Interleukin Genetics, Inc
- GNA Genotek
- Helix
- MyHeritage
- Pathway Genomics
- Veritas Genetics
- Xcode
- Color Genomics
- Myriad Genetics
- Quest Diagnostics
- Bio-Rad Laboratories, Inc.
- Illumina
- Thermo Fisher Scientific
- Qiagen
- Genomic Health
- Nebula Genomics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Personalized Genomics, By Test Type
- Market Personalized Genomics, By Technology
- Market Personalized Genomics, By Application
- Market Personalized Genomics, By End User
- Market Personalized Genomics, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing demand for personalized medicine and increase in R&D investments
- High costs and complex data interpretation
- Leveraging Big Data and Artificial Intelligence
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Personalized Genomics Market , By Test Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Oncology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Neurological Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Cardiovascular Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Personalized Genomics Market , By Technology, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- PCR-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Microarray-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Sequencing-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
6. Global Personalized Genomics Market , By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Wellness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Sports Nutrition & Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Lifestyle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
7. Global Personalized Genomics Market , By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
8. Global Personalized Genomics Market , By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of Middle East
9. Competitive Landscape
- 23andMe
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mapmygenome
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Invitea
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genetic Technology Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Interleukin Genetics, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GNA Genotek
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Helix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MyHeritage
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pathway Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Veritas Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Xcode
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Color Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Illumina
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Qiagen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genomic Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nebula Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
